documents: FDA-2020-N-1307-0023

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-1307-0023 FDA FDA-2020-N-1307 Reference 14 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:31:43Z   0 0 0900006484d81167

Links from other tables